Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schold

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|December 26, 1992
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiformeH S Friedman, M E Dolan, R C Moschel, et al.
Carcinogenesis|September 11, 1991
Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell linesL E Ostrowski, M A von Wronski, S H Bigner, et al.
Medical and Pediatric Oncology|April 1, 1995
Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasmsD H Lachance, D Oette, S C Schold, et al.
Investigative Radiology|June 1, 1993
Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic gliomaS C Schold, M R Zalutsky, R E Coleman, et al.
Applied Neurophysiology|January 1, 1983
Experience using two CT-guided stereotactic biopsy methodsD E Bullard, B S Nashold, D Osborne, et al.
AJNR. American Journal of Neuroradiology|May 1, 1993
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasiaW K Davis, O B Boyko, J M Hoffman, et al.
Journal of Computer Assisted Tomography|July 1, 1993
Serial FDG-PET studies in the prediction of survival in patients with primary brain tumorsT Schifter, J M Hoffman, M W Hanson, et al.
Neurology|September 1, 1994
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapyD H Lachance, D M Brizel, J P Gockerman, et al.
Cancer Research|May 1, 1992
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trialT J Panella, D C Smith, S C Schold, et al.
Neurology|January 1, 1989
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumorH S Friedman, S C Schold, W T Djang, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|December 26, 1992
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiformeH S Friedman, M E Dolan, R C Moschel, et al.
Carcinogenesis|September 11, 1991
Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell linesL E Ostrowski, M A von Wronski, S H Bigner, et al.
Medical and Pediatric Oncology|April 1, 1995
Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasmsD H Lachance, D Oette, S C Schold, et al.
Investigative Radiology|June 1, 1993
Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic gliomaS C Schold, M R Zalutsky, R E Coleman, et al.
Applied Neurophysiology|January 1, 1983
Experience using two CT-guided stereotactic biopsy methodsD E Bullard, B S Nashold, D Osborne, et al.
AJNR. American Journal of Neuroradiology|May 1, 1993
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasiaW K Davis, O B Boyko, J M Hoffman, et al.
Journal of Computer Assisted Tomography|July 1, 1993
Serial FDG-PET studies in the prediction of survival in patients with primary brain tumorsT Schifter, J M Hoffman, M W Hanson, et al.
Neurology|September 1, 1994
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapyD H Lachance, D M Brizel, J P Gockerman, et al.
Cancer Research|May 1, 1992
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trialT J Panella, D C Smith, S C Schold, et al.
Neurology|January 1, 1989
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumorH S Friedman, S C Schold, W T Djang, et al.
Pageof 13